Hypnotics/sedatives associated with abnormal thinking and behavior changes, including decreased inhibition, aggression, bizarre behavior, agitation, hallucinations, depersonalization. Amnesia can occur. May cause CNS depression. Use with caution in depression (worsening of depression, including suicidal ideation, reported with use of hypnotics). Use with caution in history of drug dependence, in hepatic impairment (avoid use in severe impairment), in respiratory compromise, COPD, or sleep apnea; in the elderly, and in patients receiving other CNS depressants or psychoactive medication (effects with other sedative drugs or ethanol may be potentiated). Capsules contain tartrazine (FD&C Yellow No. 5)(avoid in sensitivity (caution in asthma)). Rapid onset of action. Abrupt discontinuance may lead to withdrawal symptoms. Severe allergic reactions (anaphylaxis, angioedema) and complex sleep-related behaviors, which may include sleep-driving, making phone calls, and preparing and eating food while asleep. Zaleplon may be associated with lower potential for abuse compared to benzodiazepines.